在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Soluble Cluster of differentiation 40 ligand,sCD40L ELISA Kit

  • 中文名稱:
    人可溶性CD40配體(sCD40L)酶聯免疫試劑盒
  • 貨號:
    CSB-E04716h
  • 規格:
    96T/48T
  • 價格:
    ¥3200/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人可溶性CD40配體(sCD40L)酶聯免疫試劑盒(CSB-E04716h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的CD40LG含量。CD40LG是重要靶點。它參與免疫調節,與CD40結合激活B細胞等免疫細胞。在腫瘤免疫等領域研究較多,其阻斷或激活機制探究,有望開發新的免疫治療策略,為癌癥等疾病帶來新的治療思路和方法。試劑盒檢測范圍為0.312 ng/mL-20 ng/mL,靈敏度為0.078 ng/mL。適用于基礎醫學研究中sCD40L在免疫調控、疾病發生機制中的功能探索,或作為炎癥相關藥物開發的體外檢測工具,為評估生物標志物表達水平提供可靠技術支持。本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    CD 40L ELISA Kit; CD154 ELISA Kit; CD40 antigen ligand ELISA Kit; CD40 ligand ELISA Kit; CD40 ligand; soluble form ELISA Kit; CD40-L ELISA Kit; CD40L ELISA Kit; CD40L_HUMAN ELISA Kit; CD40LG ELISA Kit; gp39 ELISA Kit; hCD40L ELISA Kit; HIGM1 ELISA Kit; IGM ELISA Kit; IMD3 ELISA Kit; T B cell activating molecule ELISA Kit; T BAM ELISA Kit; T-cell antigen Gp39 ELISA Kit; TNF-related activation protein ELISA Kit; TNFSF5 ELISA Kit; TrAP ELISA Kit; Tumor necrosis factor (ligand) superfamily member 5 ELISA Kit; Tumor necrosis factor ligand superfamily member 5 ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.312 ng/mL-20 ng/mL
  • 靈敏度:
    0.078 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Immunology
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:

    Intra-assay Precision (Precision within an assay): CV%<8%

    Three samples of known concentration were tested twenty times on one plate to assess.

    Inter-assay Precision (Precision between assays): CV%<10%

    Three samples of known concentration were tested in twenty assays to assess.

     

    Intra-Assay Precision

    Inter-Assay Precision

    Sample

    1

    2

    3

    1

    2

    3

    n

    20

    20

    20

    20

    20

    20

    Mean(ng/ml)

    2.500

    2.489

    2.510

    2.476

    2.514

    2.507

    SD

    0.034

    0.029

    0.041

    0.054

    0.058

    0.052

    CV(%)

    3.740

    3.201

    4.496

    5.983

    6.353

    5.708

  • 線性度:

    To assess the linearity of the assay, samples were spiked with high concentrations of human sCD40L in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

     

    Sample

    Serum(n=4)

    1:1

    Average %

    95

    Range %

    85-101

    1:2

    Average %

    87

    Range %

    82-94

    1:4

    Average %

    97

    Range %

    82-105

    1:8

    Average %

    94

    Range %

    82-100

  • 回收率:

    The recovery of human sCD40L spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.

    Sample Type

    Average % Recovery

    Range

    Serum (n=5)

    92

    87-100

    Platelet-poor EDTA plasma (n=4)

    93

    85-102

  • 標準曲線:

    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

    ng/ml

    OD1

    OD2

    Average

    Corrected

    20

    2.653

    2.756

    2.705

    2.568

    10

    2.108

    2.215

    2.162

    2.025

    5

    1.524

    1.505

    1.515

    1.378

    2.5

    0.878

    0.860

    0.869

    0.732

    1.25

    0.575

    0.543

    0.559

    0.422

    0.625

    0.347

    0.334

    0.341

    0.204

    0.312

    0.258

    0.261

    0.260

    0.123

    0

    0.141

    0.132

    0.137

     

  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 最新研究進展:
    CD40L(CD154)是一種細胞表面膜蛋白,主要表達在激活的T淋巴細胞、B淋巴細胞和巨噬細胞上。最新研究表明,CD40L參與了自身免疫性疾病的發生和發展,如自身免疫性甲狀腺疾病和系統性紅斑狼瘡等。此外,CD40L還被發現在某些腫瘤細胞上表達,并參與了腫瘤免疫逃逸和抗腫瘤免疫治療的抵抗性。
     
  • 功能:
    Cytokine that acts as a ligand to CD40/TNFRSF5. Costimulates T-cell proliferation and cytokine production. Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation. Induces the activation of NF-kappa-B. Induces the activation of kinases MAPK8 and PAK2 in T-cells. Induces tyrosine phosphorylation of isoform 3 of CD28. Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4. Involved in immunoglobulin class switching.; Acts as a ligand for integrins, specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling.
  • 基因功能參考文獻:
    1. this study reports the clinical and CD40L genetic features of six Iranian hyper IgM syndrome patients PMID: 30081731
    2. Overexpression of CD40L-WT/CD40L-M in CD40+ NSCLC cells increased SA-beta-gal staining activity and inhibited DNA synthesis and cell proliferation. PMID: 30078020
    3. T cell-stimulated CLL cells actively recruited monocytes, and CD40L was identified as the responsible T-cell factor that mediated recruitment. PMID: 28971904
    4. this study shows that decreased serum levels of soluble CD40L correlate in treated patients with Relapsing-Remitting Multiple Sclerosis PMID: 29050818
    5. In conclusion, we described a new pathway of platelet-monocyte interaction, mediated by sCD40L and oxidative stress that may contribute to the progression of endothelial dysfunction during Shiga toxin 2-associated hemolytic uremic syndrome. PMID: 29068360
    6. show that sCD40L/alpha5beta1 interaction leads to platelet activation as evaluated in the human whole blood PMID: 26719354
    7. In this first X chromosome-wide association study of adult patients with IBD, we identified an IBD susceptibility locus with genome-wide significance at rs2427870 on chrXq26.3, located 66 kbp upstream of CD40LG and 83.4 kbp upstream of ARHGEF6 [OR, 1.22; combined p = 3.79 x 10-15]. PMID: 28333213
    8. Study indicates that the rs1126535C/T polymorphism of CD154 gene was involved in the progression of Chinese SLE patients, probably by affecting the expression of CD154. PMID: 28550400
    9. study found that plasma CD40L was associated with acute chest syndrome (ACS), and that sickle cell anemia (SCA)patients with a lifetime history of ACS (ACS+) presented significantly higher plasma CD40L and TSP-1 than patients who had never experienced ACS (ACS-) PMID: 28609750
    10. this paper demonstrates importance of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schonlein purpura nephritis PMID: 27837410
    11. Soluble CD40 ligand derived from serum is not correlated with early stage of multiple sclerosis. PMID: 28619427
    12. Analysis of the early events after receptor engagement revealed that both TNF and CD40L activate the classical NF-kappaB pathway, and confirm activation of the alternative by the latter. Furthermore, using genetic and pharmacological inhibition of the classical pathway we show that activation of the alternative occurs independently of the former. This reveals insights into NF-kappaB signaling by CD40L and TNF in endoth... PMID: 29183724
    13. CD40L, more than IL-6, or TNF-alpha, constitutes a predictor to explain polycystic ovary syndrome and associated features PMID: 27572328
    14. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in focal segmental glomerulosclerosis. PMID: 29155846
    15. Plasma sCD40L levels were elevated in systemic lupus erythematosis patients who had positive anti-phospholipid antibodies and experienced arterial thrombosis, suggesting that enhanced release of sCD40L through platelet activation presumably by aPL could contribute to the development of atherothrombotic disease. PMID: 28421990
    16. Higher concentrations of CD40L in patients with limited cutaneous form in our study might suggest a role for CD40/CD40L pathway in vascular pathology of systemic sclerosis. PMID: 27392528
    17. we also report for the first time that the rs1126535 C allele (CD40L gene) may predict a worse response after gastric bypass in morbidly obese patients PMID: 27681093
    18. Serum levels of sCD40L and MMP-9 are associated with the stability of carotid plaques. PMID: 28642174
    19. studies identify a novel molecular mechanism of regulation of CD40L by the transcription factor GLI2 in the tumor microenvironment downstream of CCR3 signaling PMID: 28461568
    20. data suggest that therapeutic CD40-CD40L blocking agents may prove efficacious not only in early and established rheumatoid arthritis (RA), but also in inhibiting the progression of the disease from arthralgia or undifferentiated arthritis to RA PMID: 28455435
    21. CD4(+) T cells that coexpress CD57 and CD154, which are exclusively present in cytomegalovirus-positive individuals. PMID: 27566833
    22. Serum CD40L levels were elevated in both neuromyelitis optica and multiple sclerosis patients. PMID: 27725124
    23. plasma PGE2 is correlated with the prevention of IVIG resistance and CAL formation through CD40L in KD PMID: 27525421
    24. This study provides the first evidence that human circulating group 2 innate lymphoid cells can express CD154 and stimulate the production of IgE by B lymphocytes through IL-25/IL-33 stimulation or TLR triggering PMID: 27576126
    25. data also demonstrated that the CD154-triggered inhibition of the Fas-mediated cell death response was dependent on a suppression of caspase-8 cleavage, but independent of de novo protein synthesis or alterations in Fas expression on cell surface. PMID: 27391025
    26. These results suggest soluble CD40L could have a prognostic value in ST-elevation myocardial infarction patients. PMID: 27172386
    27. persistence of helper T-cell-derived CD40L on or in B cells could permit sustained CD40 signaling enabling survival and proliferation of antigen-presenting B cells following brief interactions with helper T cells in vivo in germinal centers. PMID: 27753080
    28. These results demonstrate the feasibility of engineered nuclease-directed gene repair to restore endogenously regulated CD40L, and the potential for its use in T-cell therapy for X-HIGM syndrome. PMID: 26903548
    29. Hypertensives showed significantly enhanced soluble CD40L levels compared to normotensive controls PMID: 27090943
    30. The levels of sCD40l have no influence on survival or cardiovascular events and mortality in haemodialysis patients in a long-term follow-up PMID: 27295448
    31. CD40L gene polymorphism was found to be associated with severe falciparum malaria in Indian population especially in severe malarial anaemia. PMID: 28352049
    32. While CD40 expression tends to be relatively high in the peritumoral dermis of epithelial carcinomas, the expression of CD40L in mast cells is low in the same peritumoral area, compared with the opposite findings in psoriasis and actinic keratosis. PMID: 28267402
    33. Increased serum sCD40L levels may be related to angiogenesis in patients with multiple myeloma (MM). This protein has potential clinical usefulness in MM and may be considered as an additional prognostic marker. The correlation of sCD40L with beta-thromboglobulin may indicate that in patients with MM sCD40L derives from activated platelets. PMID: 27243341
    34. Primary Aldosteronism is related to platelet activation, expressed as higher plasma values of soluble CD40L and soluble P-selectin values. PMID: 27101095
    35. Given the crucial role of sCD40L, this haplotype study in a transfusion model may be helpful to further determine the role of haplotypes in inflammatory clinical settings. PMID: 27094978
    36. Overexpression of CD154 on CD4(+)T cells is unlikely to be central to the pathogenesis of idopathic thrombocytopenic purpura, and other immune dysfunctions should be targeted for therapy purposes. PMID: 26183367
    37. the serum levels of the soluble factors sCD40L and CXCL1 are not associated with endometriosis and are not suitable as biomarkers for disease diagnosis. PMID: 27190986
    38. Increased sCD40L plasma levels are associated with the presence of insulin resistance and not the state of glucose tolerance. PMID: 26934129
    39. we report that Kv1.3-NPs reduced NFAT activation and CD40L expression exclusively in CD45RO(+) T cells. Furthermore, Kv1.3-NPs suppressed cytokine release and induced a phenotype switch of T cells from predominantly memory to naive. PMID: 26994905
    40. mCD40L-induced cell death mediated by NORE1A expression appeared to be independent of mCD40L-induced cell death mediated by sustained JNK activation since NORE1A inhibition did not affect JNK phosphorylation and vice versa PMID: 26986513
    41. diagnostic value of soluble CD40 ligand (sCD40L) and vascular endothelial growth factor (VEGF) for Alzheimer's disease PMID: 26706786
    42. Study allows identify significant different genetic heterogeneity between two investigated populations (France and Tunisia) and revealed discrepancies in the prevalence of CD40LG polymorphisms that may be explained by ethnic and geographic differences. PMID: 26577033
    43. concentrations of the C-reactive protein, myeloperoxidase and soluble CD40 ligand taken from peripheral vein were closely similar to the concentration found in coronary blood of ACS patients PMID: 26576922
    44. Studies suggest that the CD40/CD154 pathway represents a promising potential therapeutic target for the prevention of transplantation rejection. PMID: 26268734
    45. Three single-nucleotide polymorphisms (SNPs) of the TLR8, CD40LG and IRAK1 genes on the X chromosome were genotyped. PMID: 26043172
    46. plasma soluble CD40L levels are reduced by antiplatelet therapy with clopidogrel, but not associated with long-term ischemic outcomes in unselected consecutive aspirin-treated patients undergoing cardiac catheterization. PMID: 26237513
    47. The study findings showed that plasma sCD40L, fetuin-A, and PAPP-A levels are associated with carotid plaque formation and instability. PMID: 26214492
    48. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells. PMID: 26313915
    49. CD40 ligand induces von Willebrand factor release from endothelial cells PMID: 25608503
    50. Higher plasma soluble CD40L levels on presentation are associated with clinical severity and have potential to be a good prognostic biomarker of aneurysmal subarachnoid hemorrhage. PMID: 25944664

    顯示更多

    收起更多

  • 相關疾病:
    Immunodeficiency with hyper-IgM, type 1 (HIGM1)
  • 亞細胞定位:
    Cell membrane; Single-pass type II membrane protein. Cell surface.; [CD40 ligand, soluble form]: Secreted.
  • 蛋白家族:
    Tumor necrosis factor family
  • 組織特異性:
    Specifically expressed on activated CD4+ T-lymphocytes.
  • 數據庫鏈接:

    HGNC: 11935

    OMIM: 300386

    KEGG: hsa:959

    STRING: 9606.ENSP00000359663

    UniGene: Hs.592244



主站蜘蛛池模板: 亚洲欧洲日韩综合久久| 四虎影库在线永久影院免费观看| 少妇性l交大片欧洲热妇乱xxx| 夜鲁鲁鲁夜夜综合视频欧美| 海角社区在线视频播放观看| 日本国产网曝视频在线观看| 全球成人中文在线| 永久中文字幕免费视频网站| 日韩人妻无码精品-专区| 成熟丰满熟妇高潮xxxxx| 亚洲的天堂av无码| 青青青青国产免费线在线观看| 久久俺也去丁香综合色| 亚洲精品无码鲁网午夜| 欧洲成人午夜精品无码区久久| 中日av乱码一区二区三区乱码| 精品久久久久久久久中文字幕| 国语自产拍精品香蕉在线播放| 国产产在线精品亚洲aavv| 精品综合久久久久久98| 免费国产又色又爽又黄的网站| 天天躁日日躁狠狠躁2018| 国内一区二区三区香蕉aⅴ| 黑色丝袜无码中中文字幕| 国产亚洲欧美在线专区| 亚洲色欲一区二区三区在线观看| 久久男人av资源站| 中文字幕在线精品视频入口一区| 午夜激成人免费视频在线观看| 日韩精品无码一区二区三区久久久| 久久人妻无码一区二区| 国产成人久久综合77777| 亚洲欧美在线制服丝袜国产| 乱精品一区字幕二区| 青青草国产成人99久久| 亚洲国产精品无码久久一线| 国产片av片永久免费观看| 日本不卡一区二区三区| 欧美乱色伦图片区| 国产熟女出轨做受的叫床声| 精品国产免费人成电影在线看|